Extendicare Earnings Call Transcripts
Fiscal Year 2026
-
The meeting highlighted strong financial growth, expanded home care capacity, and ongoing investments in technology and staff development. Shareholders approved all proposals, including director elections and executive compensation, while management addressed concerns about care quality, staffing, and sector challenges.
Fiscal Year 2025
-
Q4 and full-year results showed strong organic growth, margin expansion, and successful acquisitions, with adjusted EBITDA up 36.4% year-over-year and a 5% dividend increase. The CBI Home Health acquisition is set to add scale and synergies, while capital structure remains robust.
-
The acquisition creates the largest home health care platform in Canada, expanding geographic reach and service capabilities. The CAD 570 million deal is immediately accretive, with significant synergies expected within two years and a strong strategic fit for long-term growth.
-
Q3 2025 saw robust revenue and margin growth, fueled by acquisitions and strong organic demand in home healthcare. Liquidity and balance sheet strength support ongoing expansion, while demographic trends and long-term care shortages continue to drive sector growth.
-
Q2 saw double-digit revenue growth, margin expansion, and strong AFFO, driven by acquisitions and organic growth. Home health care led performance, and new Ontario funding supports future redevelopment. Liquidity remains robust, with no near-term debt maturities.
-
The meeting covered strong financial performance, board updates, and approval of all proposals, including a 5% dividend increase and major strategic acquisitions. The company completed its transformation to a capital-light model and emphasized growth in home care and managed services.
-
Q1 2025 saw strong revenue and earnings growth across all segments, with significant margin expansion and robust liquidity. Key acquisitions and asset sales support ongoing growth, while demand remains high due to demographic trends.
Fiscal Year 2024
-
Reported strong Q4 and full year results with significant growth in revenue, NOI, and margins across all segments. Expanded capacity through new home openings and acquisitions, increased dividend by 5%, and maintained a strong balance sheet to support future growth and disciplined capital allocation.
-
Q3 saw double-digit revenue growth, margin expansion, and strong performance across all segments, driven by higher demand, government funding, and strategic capital moves. Home healthcare and managed services outperformed, with continued growth expected.
-
Q2 saw double-digit revenue and NOI growth across all segments, with managed services and home healthcare now making up over half of consolidated NOI. Strong liquidity, strategic asset sales, and pending funding increases position the business for continued margin expansion and redevelopment.